TickrTrends CRL fair value analysis

A Look at Charles River Laboratories International Inc (CRL) After 3.5% Gain -- GF Value $194.23 vs Price $357.27

gurufocus.com · 2026-10-26

On October 26, 2026, Charles River Laboratories International Inc (CRL) shares rose 3.5% to $357.27, marking a notable increase in price performance amid a 52-w

TickrTrends take: Charles River Laboratories is trading at a significant premium to its GuruFocus intrinsic value estimate, with the current market price roughly 84 percent higher than the fundamental valuation metric. The recent gain does not narrow this valuation gap, and investors focused on value metrics should monitor whether the stock's pricing reflects expectations about future earnings growth in the healthcare sector that justify the current premium. Given the overvalued assessment from TickrTrends, observers may want to track if operational performance or market conditions shift to bring the valuation closer to estimated fair value.

Read the full story at gurufocus.com →

Is CRL undervalued? See TickrTrends' fair value analysis →